CT Categories: Trial Experience

A Randomised Double-Blind, Placebo-and-Active-Control, Parallel-arm, Phase III Trial with Controlled Adjustment of Dose to Evaluate the Efficacy and Safety of CG5503 Extended –Release (ER) in Subjects with Moderate to Severe Pain Due to Osteoarthritis of the Knee.

Sponsor:
Janssen Cilag
CRO:
Kendle
Study ID:
R331333PAI3008
Phase:
N/A

A Randomized, Double Blind, Parallel-Group Study of Cardiovascular Safety in Osteoarthritis or Rheumatoid Arthritis Patients with or At High Risk for Cardiovascular Disease Comparing Celecoxib with Naproxen and Ibuprofen.

Sponsor:
Pfizer
CRO:
Quintiles
Study ID:
A3191172
Phase:
N/A

A Double Blind, Randomised, Parallel Group, Dose-Ranging Study Comparing FX006 to Commercially Available Triamcinolone Acetonide Injectable Suspension in Patients with Osteoarthritis of the Knee.

Sponsor:
Flexion Therapeutics
CRO:
N/A
Study ID:
FX006-2011-001
Phase:
N/A

A Multi centre, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated with Osteoarthritis in the Knee.

Sponsor:
Carbylan Therapeutics
CRO:
Five Corners
Study ID:
COR1.1
Phase:
III

A Double-Blind, Randomized, Single-Dose Study to Assess the Safety and Efficacy of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee.

Sponsor:
Flexion Therapeutics
CRO:
N/A
Study ID:
FX006-2014-008
Phase:
N/A

A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Knee Osteoarthritis Associated with Bone Marrow Lesions.

Sponsor:
Axsome Therapeutics
CRO:
N/A
Study ID:
AXS02-K301 COAST-1
Phase:
IIa

A randomised, double-blind using blinded evaluator, placebo and active controlled, pilot study to evaluate the safety and efficacy of intra articular administration of Articul One in patient with symptomatic primary knee osteoarthritis.

Sponsor:
Medytox
CRO:
Clinical Network Services
Study ID:
MT-GPRT-KOA01
Phase:
N/A

A Phase 2A, Randomized, Double-Blind, Placebo-Controlled, Multiple Center, Multiple-Dose Study to Assess the Efficacy and Safety of ZYN002 Administered as a Transdermal Gel to Patients with Knee Pain due to Osteoarthritis.

Sponsor:
Zynerba Pharmaceuticals
CRO:
Novotech
Study ID:
ZYN2-CL-005
Phase:
IIa

A Phase IIa, Randomized, Double-blinded, Placebo-controlled, Dose-finding Study for Single-Dose Administration of TLC599 in Patients with Osteoarthritis (OA) of Knee.

Sponsor:
Taiwan Liposome Company
CRO:
Novotech
Study ID:
TLC559A2003
Phase:
IIa

A Phase 3, Randomized, Double-blind, Placebo- and Active controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee.

Sponsor:
Taiwan Liposome Company
CRO:
Premier Research
Study ID:
TLC599A3005
Phase:
III